Alector (ALEC) Current Leases (2019 - 2026)
Alector's (ALEC) quarterly Current Leases came in at $9.2 million in Q2 2026, up 3.45% year-over-year from $8.9 million in Q2 2025, and up 0.83% quarter-over-quarter from $9.1 million in Q1 2026.
Analysis
Alector (ALEC) Current Leases (2019 - 2026) Analysis & Trends
Alector (ALEC) has reported Current Leases for 8 consecutive years, with $9.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Leases rose 3.45% year-over-year to $9.2 million in Q2 2026; TTM through Jun 2026 was $9.2 million, a 3.45% increase from a year earlier, with the FY2025 full-year figure at $9.1 million, up 3.45% from the prior year.
- Current Leases was $9.2 million for Q2 2026 at Alector, up from $9.1 million in the prior quarter.
- Over five years, Current Leases peaked at $9.2 million in Q2 2026 and troughed at $7.9 million in Q1 2022.
- A 5-year average of $8.5 million and a median of $8.6 million in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases rose 2.04% in 2022 and gained 5.01% in 2023, its largest moves.
- Over 5 years, Current Leases stood at $8.1 million in 2022, then advanced by 5.0% to $8.5 million in 2023, then gained by 3.45% to $8.8 million in 2024, then climbed by 3.45% to $9.1 million in 2025, then grew by 1.71% to $9.2 million in 2026.
- The last three Current Leases figures came in at $9.2 million (Q2 2026), $9.1 million (Q1 2026), and $9.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 9.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.21 Mn |
| Mar 31, 2026 | 9.14 Mn |
| Dec 31, 2025 | 9.06 Mn |
| Sep 30, 2025 | 8.98 Mn |
| Jun 30, 2025 | 8.90 Mn |
| Mar 31, 2025 | 8.83 Mn |
| Dec 31, 2024 | 8.75 Mn |
| Sep 30, 2024 | 8.68 Mn |
| Jun 30, 2024 | 8.61 Mn |
| Mar 31, 2024 | 8.54 Mn |
| Dec 31, 2023 | 8.46 Mn |
| Sep 30, 2023 | 8.39 Mn |
| Jun 30, 2023 | 8.20 Mn |
| Mar 31, 2023 | 8.13 Mn |
| Dec 31, 2022 | 8.06 Mn |
| Sep 30, 2022 | 7.99 Mn |
| Jun 30, 2022 | 7.92 Mn |
| Mar 31, 2022 | 7.86 Mn |
| Dec 31, 2021 | 7.80 Mn |
| Sep 30, 2021 | 7.79 Mn |